Sure maybe they didn't anticipate the slide but there's a couple...

Sure maybe they didn't anticipate the slide but there's a couple of things to consider in the next 10 months:

1. The market will recover. It might not get us back to ATH but there seems to be a general consensus that we're oversold. So maybe we get back to 50c in the near term.
2. The $1 SP target would put our MC at $1.27B. Is that really that crazy if positive results continue? We know the TAMs for these drugs are off the charts.

Sentiment is lulling right now as there's nothing concrete on the horizon short term. But that won't last for long. I'm expecting a solid update on next steps for Apirx strategy / timelines which could prove very interesting.